Progress in proteomic marker-assisted selection for honey bees (Apis mellifera)
FAS-selected stock exhibited relative increases in hygienic behavior of 28.6, 19.9 and 31.7% over benchmark populations in the F1- F3 generations, respectively. Similar, though smaller, gains were observed for the MAS-selected stock where levels of HB increased 10.6, 13.0, and 20.1 % over benchmark populations for the F1 through the F3. Progeny for each generation were also evaluated for Varroa Sensitive Hygiene. Overall, F3 colonies showed a reduction in Varroa-infested brood of 38.8 ± 5.6% for FAS-selected stock and 40.2± 4.2 % for MAS-selected stock, compared with benchmark stock at 21.9 ± 3.9 %. Nevertheless, the fertility of mites remaining in the brood remained unchanged for FAS and MAS selected stock over three generations (combined mean of 89.8 ± 1.1 %) , and similar to the benchmark population.
Both FAS and MAS selected stocks were also evaluated via whole-colony challenge experiments with American foulbrood disease (AFB) and V. destructor. Clear evidence of improved colony-level resistance to AFB was observed for FAS and MAS stocks in the F1 and F3 generations for several parameters, including the numbers of clinical symptoms of AFB in colonies over time, the proportion of colonies infected, as well as overwintering survival. Resistance to V. destructor was associated with increased levels of hygienic behavior, lower mite infestations on adult bees and improved wintering survival. Further results, including those relating to the economic performance of the selected stocks, will be discussed.
Our data are first to show the enrichment of disease and mite resistance using proteomic markers and the utility of this novel technology in bee breeding.